RenovoRx, Inc. (RNXT) Stock Ticker
RNXT right now
Market factors today
Unlock the full RNXT picture
About RenovoRx, Inc.
RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative drug and device combination. It integrates intra-arterial gemcitabine with the RenovoCath system, currently progressing through pivotal Phase III clinical trials for the treatment of locally advanced pancreatic cancer. Established in 2009, RenovoRx, Inc. maintains its headquarters in Los Altos, California.
RNXT stock facts
| Ticker symbol | RNXT |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $74.8M |
| CEO | Shaun R. Bagai |
| Employees | 17 |
| Headquarters | Mountain View, CA, US |
| IPO date | 2021-08-26 |
| Website | renovorx.com |
What you can see for RNXT on Tickr
Live RNXT price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the RNXT report.
Rankings
FAQ
What is the ticker symbol for RenovoRx, Inc.?
The ticker symbol for RenovoRx, Inc. is RNXT, listed on the NASDAQ Capital Market.
What is RNXT?
RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative drug and device combination. It integrates intra-arterial gemcitabine with the RenovoCath system, currently progressing through pivotal Phase III clinical trials for the treatment of locally advanced…